Without clinical lipodystrophy | With clinical lipodystrophy | |||||
---|---|---|---|---|---|---|
Framingham risk score | Without MS | With MS | Total | Without MS | With MS | Total |
Low risk (< 5%) [n (%)] | 27 (45.8) | 20 (29.4) | 47 (37.0) | 36 (41.9) | 23 (21.5) | 59 (30.6) |
Average (5%-9%) [n (%)] | 21 (35.6) | 22 (32.4) | 43 (33.9) | 31 (36.0) | 31 (29.0) | 62 (32.1) |
Moderate risk (10-19%) [n (%)] | 7 (11.9) | 13 (19.1) | 20 (15.7) | 15 (17.4) | 31 (29.0) | 46 (23.8) |
High risk (20-39%) [n (%)] | 3 (5.1) | 12 (17.6) | 15 (11.8) | 2 (2.3) | 20 (18.7) | 22 (11.4) |
Very high risk (> 40%) [n (%)] | 1 (1.7) | 1 (1.5) | 2 (1.6) | 2 (2.3) | 2 (1.9) | 4 (2.1) |
p | 0.078 | < 0.001 |